Wednesday, June 24, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 874 of 1,261

  1. US 8431690

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  2. US 8431605

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  3. US 8431615

    Dose forms

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  4. US 8431556

    C-21-keto lupane derivatives preparation and use thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  5. US 8431566

    Cyclopamine lactam analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  6. US 8431176

    Liquid chromatographic fraction of enzymatically polymerized flavonoid as an antioxidant

    The United States of America as represented by the Secretary of the Army · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  7. US 8430832

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  8. US 8431124

    Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)

    HALOZYME, INC. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  9. US 8431134

    Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  10. US 8431116

    Norovirus vaccine formulations

    Takeda Vaccines (Montana), Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  11. US 8431154

    Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient

    TAKEDA GMBH · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  12. CA 2852397

    UTILISATION DE GLYCOSAMINOGLYCANES SULFATES POUR AMELIORER LA BIODISPONIBILITE DU FACTEUR VIII

    CSL BEHRING GMBH [DE] · Granted Apr 25, 2013 · Expires Apr 20, 2033

    granted

  13. CA 2851057

    UTILISATION COMBINEE D'UN GLYCOSAMINOGLYCANE SULFATE ET D'UNE HYALURONIDASE POUR AMELIORER LA BIODISPONIBILITE DU FACTEUR VIII

    CSL BEHRING GMBH [DE] · Granted Apr 25, 2013 · Expires Apr 20, 2033

    granted

  14. US 8426585

    Compounds comprising a spiro-ring

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  15. US 8426574

    Identification of astrovirus VA1 associated with gastroenteritis in humans

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  16. US 8426444

    Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  17. US 8425446

    Selective cytopheresis devices and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  18. US 8425447

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  19. US 8425459

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  20. US 8425492

    In vivo device, system and usage thereof

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  21. US 8425653

    Plasmon mediated photoinduced synthesis of silver triangular bipyramids

    Northwestern University · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  22. US 8426179

    Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme

    Northwestern University · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  23. US 8426188

    Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  24. US 8425930

    Prebiotic oligosaccharides

    The Regents of the University of California · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.